During the past decade, Fuwai Central China Cardiovascular Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fuwai Central China Cardiovascular Hospital" #1 sponsor was "Henan Institute of Cardiovascular Epidemiology" with 6 trials, followed by "Ruijin Hospital" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Beijing Anzhen Hospital" with 1 trials sponsored and "Biotyx Medical (Shenzhen) Co., Ltd." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fuwai Central China Cardiovascular Hospital" #1 collaborator was "Fuwai Yunnan Cardiovascular Hospital" with 2 trials as a collaborator, "BSC International Medical Trading (Shanghai) Co., Ltd." with 1 trials as a collaborator, "Beijing Anzhen Hospital" with 1 trials as a collaborator, "Chinese Society of Cardiology" with 1 trials as a collaborator and "Med-X Research Institute, Shanghai Jiao Tong University" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Fuwai Central China Cardiovascular Hospital" are "Coronary Artery Disease" (4 trials), "Coronary Heart Disease" (3 trials), "Coronary Disease" (2 trials), "ST Elevation Myocardial Infarction" (2 trials) and "Antiplatelet Therapy" (1 trials). Many other conditions were trialed in "Fuwai Central China Cardiovascular Hospital" in a lesser frequency.

Most popular intervention types in "Fuwai Central China Cardiovascular Hospital" are "Device" (6 trials), "Other" (6 trials), "Drug" (3 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abbott Mechanical Heart Valve (MHV) Regent™" (1 trials), "Antihypertensive drugs" (1 trials), "Bivalirudin" (1 trials), "CAG-guided strategy" (1 trials) and "Cook lunderquist guidewire" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fuwai Central China Cardiovascular Hospital" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Fuwai Central China Cardiovascular Hospital". 1 are not yet recruiting, 12 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fuwai Central China Cardiovascular Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fuwai Central China Cardiovascular Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".